Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (HK:3320)
HKEX:3320
RESEARCH TOOLSreports
China Resources Pharmaceutical Group Ltd. (3320) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
3320 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
3320 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:3320 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
3320 Financial Forecast
Detailed List of Analyst Forecasts
Morgan Stanley
HK$7.8
Buy
46.62%
Upside
Reiterated
03/28/24
Morgan Stanley Reiterates Overweight Rating on China Resource Pharamaceutical Group (3320:HK)Morgan Stanley analyst Laurence Tam reiterated an Overweight rating and HK$7.80 price target on China Resource Pharamaceutical Group (3320:HK).
Nomura
HK$9.08→HK$8.8
Buy
65.41%
Upside
Reiterated
03/11/24
China Resource Pharamaceutical Group (3320:HK) PT Lowered to HK$8.80 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on China Resource Pharamaceutical Group (3320:HK) to HK$8.80 (from HK$9.08) while maintaining a Buy rating.
Best Analysts Covering China Resources Pharmaceutical Group Ltd.
Which Analyst Should I Follow If I Want to Buy HK:3320 and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/2 ratings generated profit
Average Return
+7.50%
reiterated a buy rating 4 months ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +7.50% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
3320 Analyst Recommendation Trends
Rating
Sep 23
Jan 24
Mar 24
Strong Buy
1
2
4
Buy
0
0
0
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
4
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
3320 Stock Forecast FAQ
What is HK:3320’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:3320’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:3320, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is China Resources Pharmaceutical Group Ltd. a Buy, Sell or Hold?
Currently, no data Available
What is China Resources Pharmaceutical Group Ltd.’s share price target?
Currently, no data Available
What do analysts say about China Resources Pharmaceutical Group Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of China Resources Pharmaceutical Group Ltd.?
To buy shares of HK:3320, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.